Anthony Doyle's Net Worth
Anthony Doyle's net worth is estimated to be at least $924,660.84 as of 11/22/2024. CoreStreet's estimation of Anthony Doyle's net worth is based on their sale of stock and current holding of stock.
Anthony Doyle is CFO at BioCryst Pharmaceuticals Inc. They have executed at least 4 trades of stock as per SEC Form 4 filings. Their most recent trade was for 36,300 units of BCRX stock on 05/14/2024. Their biggest sale was on 12/15/2022 when they sold 5,700 units of BioCryst Pharmaceuticals Inc stock for $62,130.00. They typically trade 1 times per year.
Total value of insider buys:
- $862,530.84
Total value of insider sells:
- $62,130.00
Most recent insider trade:
- May 14, 2024
Anthony Doyle's Insider Trading History
| BioCryst Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
May 14, 2024 | CFO | 36,300 | $5.57 | Buy | $202,191.00 |
Dec. 15, 2022 | CFO | 5,700 | $10.90 | Sell | $62,130.00 |
Nov. 23, 2021 | CFO | 35,258 | $12.48 | Buy | $440,019.84 |
Aug. 11, 2020 | CFO | 54,000 | $4.08 | Buy | $220,320.00 |